KYIV, Dec 7 – Ukraine has been focusing on growing generic drug production amid lack of financial resources to develop its own innovative drugs, Dmytro Shymkiv, the chairman of the board of directors of Darnitsa Group, said.

"For the production of innovative drugs, we need research and development and patent protection of intellectual property not only in Ukraine, but also globally,” Shymkiv told Interfax-Ukraine. “We also need the ability to raise from $ 1 billion and have at least 8-10 years of time. The availability of such resources in Ukraine is not yet discussed."